Information

1185 Avenue of the Americas, 3rd Floor

New York NY 10036

844 967 2633

www.oramed.com

Industry: Biotechnology

Sector: Healthcare

Oramed Pharmaceuticals Inc.

Description

Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for the treatment of individuals with diabetes. It is also developing ORMD-0901, an oral glucagon-like peptide-1 capsule that has completed phase I clinical trials for the treatment of type 2 diabetes; and a weight loss treatment in the form of an oral leptin capsule. The company was formerly known as Integrated Security Technologies, Inc. and changed its name to Oramed Pharmaceuticals Inc. in April 2006. Oramed Pharmaceuticals Inc. was founded in 2002 and is based in New York, New York.

Click to get the best stock tips daily for free!
ABOUT ORAMED PHARMACEUTICALS INC.
Oramed Pharmaceuticals.
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for the treatment of individuals with diabetes. It is also developing ORMD-0901, an oral glucagon-like peptid...
GOLDEN STAR
Ticker Change Signal Date
SMAR
$56.02
0.196% Dec 03
G
GOF
$15.83
0.790% Dec 02
QSR
$69.61
0.165% Nov 29
HP
$34.63
0.462% Nov 29
B
BSCO
$21.11
0.0947% Nov 27

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE